These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 3906398)
21. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats. Akbar DH; Hagras MM; Amin HA; Khorshid OA J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):103-15. PubMed ID: 23077081 [TBL] [Abstract][Full Text] [Related]
22. [Captopril and enalapril in the treatment of renal hypertension]. Hasanagić H; Djukanović Lj; Subotić Z; Nesić V; Cavrić G Srp Arh Celok Lek; 1990; 118(7-8):285-90. PubMed ID: 2097777 [TBL] [Abstract][Full Text] [Related]
23. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment. Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024 [TBL] [Abstract][Full Text] [Related]
24. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811 [TBL] [Abstract][Full Text] [Related]
25. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Insua A; Ribstein J; Mimran A Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298 [TBL] [Abstract][Full Text] [Related]
26. Effect of camostat mesilate on heavy proteinuria in various nephropathies. Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Futaki G Clin Nephrol; 1989 Sep; 32(3):119-23. PubMed ID: 2791362 [TBL] [Abstract][Full Text] [Related]
27. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis]. Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition. Vora JP; Leese GP; Peters JR; Owens DR J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336 [TBL] [Abstract][Full Text] [Related]
29. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy. Katavetin P; Eiam-Ong S; Suwanwalaikorn S J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. Sinsakul M; Sika M; Rodby R; Middleton J; Shyr Y; Chen H; Han E; Lehrich R; Clyne S; Schulman G; Harris R; Lewis J Am J Kidney Dis; 2007 Dec; 50(6):946-51. PubMed ID: 18037095 [TBL] [Abstract][Full Text] [Related]
31. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases. Liou HH; Huang TP; Campese VM Nephron; 1995; 69(1):41-8. PubMed ID: 7891796 [TBL] [Abstract][Full Text] [Related]
32. Effects of captopril on diabetic nephropathy in hypertensive women. Gonzalez-Sicilia de Llamas L; Garcia Alberola A; Lafuente Lopez-Herrera M; Fuente Jimenez T; Fernandez Pardo J; Hernandez Cascales J Eur J Clin Pharmacol; 1991; 41(5):405-9. PubMed ID: 1761066 [TBL] [Abstract][Full Text] [Related]
33. [The effect of captopril on proteinuria in glomerular diseases]. Yamaguchi Y; Saito T; Obara K; Ootaka T; Akiu N; Sato H; Kinoshita Y; Seino J; Tsunoda K; Yasujima M Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1009-16. PubMed ID: 2263022 [TBL] [Abstract][Full Text] [Related]
34. Captopril, an angiotensin I-converting enzyme inhibitor, decreases proteinuria in hypertensive patients with renal diseases. Ikeda T; Nakayama D; Gomi T; Sakurai J; Yamazaki T; Yuhara M Nephron; 1989; 52(1):72-5. PubMed ID: 2651951 [TBL] [Abstract][Full Text] [Related]
35. [Effects of angiotensin I converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension]. Aoi W; Akahoshi M; Takahara A; Doi Y; Seto S; Kusano E; Suzuki S; Hashida K; Takagi H; Yoshioka M Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1571-83. PubMed ID: 3007820 [No Abstract] [Full Text] [Related]
36. Efficacy of captopril treatment in children with steroid-resistant nephrotic syndrome. Sözüer DT; Emre S; Tanman F; Sirin A; Nayir A; Uysal V Acta Paediatr Jpn; 1994 Dec; 36(6):658-61. PubMed ID: 7871977 [TBL] [Abstract][Full Text] [Related]
37. [Effect of combination therapy of low protein diet and captopril on proteinuria of diabetic nephropathy (DN)]. Yamato E; Yokoyama K; Kitamura E; Okada N; Nakanishi I; Thubakihara Y; Iida N Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):91-5. PubMed ID: 3290554 [No Abstract] [Full Text] [Related]
38. Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients. Romero R; Salinas I; Lucas A; Teixidó J; Audi L; Sanmarti A Diabetes Res Clin Pract; 1992 Sep; 17(3):191-8. PubMed ID: 1425158 [TBL] [Abstract][Full Text] [Related]
39. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Hod M; van Dijk DJ; Karp M; Weintraub N; Rabinerson D; Bar J; Peled Y; Erman A; Boner G; Ovadia J Nephrol Dial Transplant; 1995 Dec; 10(12):2328-33. PubMed ID: 8808235 [TBL] [Abstract][Full Text] [Related]
40. Antiproteinuric effect of angiotensin-converting-enzyme inhibitors in patients with primary glomerular disease and normal renal function. Fabbri A; Cocchi R; Degli Esposti E; Lucatello A; Sturani A; Tampieri G; Fusaroli M Nephrol Dial Transplant; 1990; 5 Suppl 1():81-3. PubMed ID: 2129469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]